Dysregulation of mTOR Signaling in Neuropsychiatric Disorders: Therapeutic Implications

被引：26
|
作者：
Sawicka, Kirsty [1 ]
Zukin, R. Suzanne [1 ]
机构：
[1] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2012年 / 37卷 / 01期
关键词：
FRAGILE-X-SYNDROME; AUTISM;
D O I：
10.1038/npp.2011.210
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：305 / 306
页数：3
相关论文
共 50 条
  • [1] Dysregulation of mTOR Signaling in Neuropsychiatric Disorders: Therapeutic Implications
    Kirsty Sawicka
    R Suzanne Zukin
    Neuropsychopharmacology, 2012, 37 : 305 - 306
  • [2] Dysregulation of the mTOR signaling pathway in the pathogenesis of autism spectrum disorders
    Gabryel, Bozena
    Kapalka, Agata
    Sobczyk, Wojciech
    Labuzek, Krzysztof
    Gaweda, Agnieszka
    Janas-Kozik, Malgorzata
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2014, 68 : 375 - 383
  • [3] Inhibition of PIKfyve Leads to Lysosomal Disorders via Dysregulation of mTOR Signaling
    Xia, Jianhong
    Wang, Haiyun
    Zhong, Zhihang
    Jiang, Jun
    CELLS, 2024, 13 (11)
  • [4] BDNF-TrkB signaling as a therapeutic target in neuropsychiatric disorders
    Du, Xin
    Wu, Yeewen C.
    Hill, Rachel Anne
    JOURNAL OF RECEPTOR LIGAND AND CHANNEL RESEARCH, 2014, 7 : 61 - 79
  • [5] Iron metabolism dysfunction in neuropsychiatric disorders: Implications for therapeutic intervention
    Duarte-Silva, Eduardo
    Maes, Michael
    Peixoto, Christina Alves
    BEHAVIOURAL BRAIN RESEARCH, 2025, 479
  • [6] NEUROPSYCHIATRIC DISORDERS ASSOCIATED WITH NUTRITIONAL DEFICIENCIES - INCIDENCE AND THERAPEUTIC IMPLICATIONS
    CARNEY, MWP
    CNS DRUGS, 1995, 3 (04) : 279 - 290
  • [7] mTOR complexes in neurodevelopmental and neuropsychiatric disorders
    Costa-Mattioli, Mauro
    Monteggia, Lisa M.
    NATURE NEUROSCIENCE, 2013, 16 (11) : 1537 - 1543
  • [8] mTOR complexes in neurodevelopmental and neuropsychiatric disorders
    Mauro Costa-Mattioli
    Lisa M Monteggia
    Nature Neuroscience, 2013, 16 : 1537 - 1543
  • [9] mTOR and rapamycin in the kidney: signaling and therapeutic implications beyond immunosuppression
    Huber, Tobias B.
    Walz, Gerd
    Kuehn, E. Wolfgang
    KIDNEY INTERNATIONAL, 2011, 79 (05) : 502 - 511
  • [10] MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction
    Xu, Bin
    Hsu, Pei-Ken
    Karayiorgou, Maria
    Gogos, Joseph A.
    NEUROBIOLOGY OF DISEASE, 2012, 46 (02) : 291 - 301
12345